Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Remicade “Black Box” Warning On Risk Of Lymphoma Added To Label

This article was originally published in The Pink Sheet Daily

Executive Summary

J&J/Centocor cite six reports of hepatosplenic T-cell lymphoma post-marketing in patients taking concomitant immunosuppressants.

You may also be interested in...



TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry

The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.

TNF Blockers Not Seen To Boost Cancer Risk In RA Patients Tracked In Large Spanish Registry

The only elevated cancer type in patients taking the biologic drugs was non-melanoma skin cancer, investigator reports at rheumatology scientific conference.

Enbrel “Black Box” Under Consideration By FDA, Amgen Execs Say

Amgen also has received two federal subpoenas related to its products, the firm discloses.

Topics

UsernamePublicRestriction

Register

OM007836

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel